Onderneming Tetra Bio Pharma Inc Canadian Securities Exchange
Aandelen
TBP
CA88166Y1007
Farmaceutische producten
Vakgebied
Managers
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Guy Chamberland
CEO | Chief Executive Officer | - | 01-06-16 |
Natalie Leroux
IRC | Investor Relations Contact | - | - |
Michael Olders
PRN | Corporate Officer/Principal | - | - |
Derek Theriault
PRN | Corporate Officer/Principal | - | - |
Dania Scott
PRN | Corporate Officer/Principal | - | 04-09-20 |
Aurelia de Pauw
PRN | Corporate Officer/Principal | - | 01-10-18 |
Steeve Néron
PRN | Corporate Officer/Principal | - | 13-11-18 |
Corporate Officer/Principal | - | 05-06-18 |
Besturend
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Guy Chamberland
CEO | Chief Executive Officer | - | 01-06-16 |
Catherine Auld
BRD | Director/Board Member | - | 28-05-21 |
H. Norton
CHM | Chairman | 63 | 17-09-20 |
Director/Board Member | 68 | 17-09-20 | |
John Kim
BRD | Director/Board Member | - | 28-05-21 |
Aandelenklasse
Stemming | Aantal | Vrij verhandelbaar | Bedrijfseigen aandelen | Drijvend Totaal | |
---|---|---|---|---|---|
Aandeel A | 1 | 515 634 205 | 510 507 769 ( 99,01 %) | 0 | 99,01 % |
Bedrijfsgegevens
Sector
Vaira. 1 jan. | Kapi. | |
---|---|---|
+41,50% | 6,2 mld. | |
-22,89% | 4,1 mld. | |
+9,36% | 3,41 mld. | |
-19,39% | 2,83 mld. | |
-11,05% | 2,29 mld. | |
+45,24% | 1,93 mld. | |
-7,51% | 1,52 mld. | |
+46,81% | 1,51 mld. | |
-18,04% | 1,49 mld. |